Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
QuintilesIMS
Julphar
Argus Health
Cipla
Harvard Business School
Covington
Colorcon

Generated: September 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078538

« Back to Dashboard

NDA 078538 describes DILTIAZEM HYDROCHLORIDE, which is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Apotex, Biovail, Mylan, Nesher Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Sun Pharma Global, Teva, Twi Pharms, Valeant Pharms North, Zydus Pharms Usa Inc, Akorn Inc, Athenex Inc, Hikma Farmaceutica, Hospira, Intl Medication, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Apothecon, Chartwell Molecules, Ivax Sub Teva Pharms, and Teva Pharms, and is included in thirty-eight NDAs. It is available from forty suppliers. Additional details are available on the DILTIAZEM HYDROCHLORIDE profile page.

The generic ingredient in DILTIAZEM HYDROCHLORIDE is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Summary for 078538
Tradename:DILTIAZEM HYDROCHLORIDE
Applicant:West-ward Pharms Int
Ingredient:diltiazem hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 078538
Mechanism of ActionCalcium Channel Antagonists
Suppliers and Packaging for NDA: 078538
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 078538 ANDA West-ward Pharmaceutical Corp. 0641-6013 0641-6013-10 10 VIAL in 1 CARTON (0641-6013-10) > 5 mL in 1 VIAL (0641-6013-01)
DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 078538 ANDA West-ward Pharmaceutical Corp. 0641-6014 0641-6014-10 10 VIAL in 1 CARTON (0641-6014-10) > 10 mL in 1 VIAL (0641-6014-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5MG/ML
Approval Date:Dec 17, 2008TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
Deloitte
Colorcon
Express Scripts
McKesson
Johnson and Johnson
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.